Ilett EE, Jørgensen M, Noguera-Julian M, et al. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv. 2020;4(22):5797-5809.

Page 5806: In the “Myeloblative” and “Female” rows of Figure 6, the adjusted odds ratios are mismatched. The odds ratio for “Myeloblative” should be “2.95 (1.35-6.47),” and the odds ratio for “Female” should be “2.21 (1.01-4.86).” The corrected Figure 6 is shown below.

Figure 6.

Clinical factors associated with aGVHD. Multivariable logistic regression model of clinical factors associated with the development of aGVHD. aOR, adjusted odds ratio; Ref, reference.